KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Revenue (2016 - 2025)

Historic Revenue for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $11.4 billion.

  • Abbott Laboratories' Revenue rose 690.17% to $11.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $43.8 billion, marking a year-over-year increase of 637.12%. This contributed to the annual value of $42.0 billion for FY2024, which is 459.0% up from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Revenue is $11.4 billion, which was up 690.17% from $11.1 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Revenue registered a high of $11.9 billion during Q1 2022, and its lowest value of $9.7 billion during Q1 2023.
  • Over the past 5 years, Abbott Laboratories' median Revenue value was $10.4 billion (recorded in 2022), while the average stood at $10.6 billion.
  • In the last 5 years, Abbott Laboratories' Revenue surged by 3950.6% in 2021 and then tumbled by 1805.8% in 2023.
  • Abbott Laboratories' Revenue (Quarter) stood at $11.5 billion in 2021, then decreased by 12.01% to $10.1 billion in 2022, then increased by 1.49% to $10.2 billion in 2023, then rose by 7.16% to $11.0 billion in 2024, then grew by 3.6% to $11.4 billion in 2025.
  • Its last three reported values are $11.4 billion in Q3 2025, $11.1 billion for Q2 2025, and $10.4 billion during Q1 2025.